A Pricey Lesson in Disclosure and Due Diligence
Though the settlement is not an admission of wrongdoing, it sends a sharp message about the perils of cutting corners in disclosure and the enduring reach of federal watchdogs. InnovAge may have sold a vision of accessible senior care at scale — but investors were ultimately left holding the bill when regulatory reality collided with Wall Street optimism.
The court’s final approval hearing is expected later this year, where the deal could be cemented — and a bruised investor class may finally see restitution.